Skip to main content
. 2022 Mar 15;13:830030. doi: 10.3389/fphar.2022.830030

TABLE 11.

SUCRA results of the outcomes.

APACHE II score (%) 28-days mortality (%) PCT (%) CRP (%) IL-6 (%) TNF-α (%) CD4+ (%) CD8+ (%) CD4+/CD8+ (%)
WM 2.4 18.4 17.4 8.5 4.1 16.8 1.5 49.3 5.4
SF + WM 38.8 74.8 64.6 30.9 99.5 99.4 42.5 23 35.9
SM + WM 52.8 94.4 94.8 61.8 62.2 60.6 6.9 59.1
SGM + WM 32.8 63.3 71.9 51.4 64.2 68.7
SQFZ + WM 82.3 38 83.1 45.5 49.5 62.1 78.7 55.9
HQ + WM 91 43.5 13.8 31.2 24.8 3.4 83.3 92.2 93.6